Analgesics is expected to perform well in 2021, with value growth on par with 2020. COVID-19 is still influencing consumer behaviour as infection rates remain high for much of 2021.
Analgesics is one of the most established and mature product areas within consumer health in Ukraine. Such products are popular amongst Ukrainians, who often aim to alleviate symptoms through painkillers alone and often follow self-care than choose to visit a doctor.
Multinational players Teva Ukraine and Reckitt Benckiser Household & Healthcare Ukraine lead analgesics in 2021, benefitting from early entry, promotional support for brands through strong advertising and with consumers perceiving imported brands to be more effective. The Leading brand Nurofen from Reckitt Benckiser Household & Healthcare Ukraine, has been aggressively advertised since its launch, and benefits from being recognised as "Nurofen" rather than a type of ibuprofen.
COVID-19 has been a boon for analgesics. However, once the virus is brough under control, value growth in analgesics will return to lower, more normal growth patterns.
Combination products will continue to be the largest product area, as their multiples effects appeal to consumers. However, it will lose value share over the forecast period.
Over the forecast period, in what is a mature product area, the competitive landscape will be cut throat. International players will continue investing heavily in promotion to attract consumers and maintain their loyalty for their comparatively expensive products.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Analgesics industry in Ukraine with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Ukraine, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).See All of Our Definitions
This report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!